News

The Link Between MTHFR Folate Metabolism Gene and Pregnancy-Induced Hypertension
MTHFR, or methylenetetrahydrofolate reductase, is a crucial enzyme in the metabolism of folate, tasked with converting 5,10-methylenetetrahydrofolate into 6S-5-methyltetrahydrofolate, a form readily absorbed by the human body. In China, a significant portion of the population—78.4%—struggles with MTHFR folate metabolism disorders.
Learn More
Dr. Lian Zengli Takes on Committee Role at Women and Children's Health Conference
Changsha, China - November 16, 2024 - We are pleased to share that Dr. Lian Zengli, our Chief Scientist, has been elected as a Standing Committee Member of the Nutrition Metabolism and Genetic Disease Prevention and Treatment Special Committee at the inaugural China Women and Children's Health Medical Science and Technology Conference.
Learn More
Safeguarding Pregnancy Health: How Naturalization Folate Helps Prevent Preeclampsia
Preeclampsia is a hypertensive disorder unique to pregnancy, characterized by high blood pressure and proteinuria. It can lead to severe complications such as premature birth, restricted fetal growth, and placental abruption, posing significant risks to both maternal and fetal health. It is a major cause of maternal mortality worldwide. Recent scientific research has increasingly focused on the relationship between biomarkers like folate, homocysteine (HCY), and vitamin B12, and the risk of preeclampsia.
Learn More
Preeclampsia Risk and Early Pregnancy Homocysteine Levels: The Protective Role of 6S-5-Methyltetrahydrofolate
Preeclampsia, a condition unique to pregnancy, affects 5-10% of expecting mothers and is a significant threat to both maternal and fetal health, being a leading cause of maternal and perinatal mortality. Recent studies have revealed a strong correlation between homocysteine (HCY) levels in early pregnancy and the risk of developing preeclampsia.
Learn More
The Impact of MTHFR Gene Polymorphisms on Folate Metabolism and Preeclampsia Risk
Preeclampsia, a complex disorder unique to pregnancy, is characterized by high blood pressure and proteinuria, typically emerging after the 20th week of gestation. It poses significant risks to both the mother and the fetus. While the exact etiology remains elusive, it is believed to involve genetic, immunological, and endothelial dysfunction factors.
Learn More
Preeclampsia and Folate: The Potential of 5-Methyltetrahydrofolate (5-MTHF) in Preeclampsia Prevention
Preeclampsia, a stealthy threat during pregnancy, has long been a source of concern for countless families. It poses a risk to both maternal health and fetal development. In the quest for effective preventative measures, the medical community has made significant strides with a recent discovery—5-Methyltetrahydrofolate (5-MTHF).
Learn More

<...7891011...92>

Latest Products

About US

Featured News

Dr. Lian Zengli Takes on Committee Role at Women and Children's Health Conference

Safeguarding Pregnancy Health: How Naturalization Folate Helps Prevent Preeclampsia

Featured News

Dr. Lian Zengli Takes on Committee Role at Women and Children's Health Conference

Safeguarding Pregnancy Health: How Naturalization Folate Helps Prevent Preeclampsia

Consulting Service

If you have any questions, please contact us!

The Link Between MTHFR Folate Metabolism Gene and Pregnancy-Induced Hypertension

Learn More

Dr. Lian Zengli Takes on Committee Role at Women and Children's Health Conference

Learn More

Safeguarding Pregnancy Health: How Naturalization Folate Helps Prevent Preeclampsia

Learn More

Preeclampsia Risk and Early Pregnancy Homocysteine Levels: The Protective Role of 6S-5-Methyltetrahydrofolate

Learn More

The Impact of MTHFR Gene Polymorphisms on Folate Metabolism and Preeclampsia Risk

Learn More

Preeclampsia and Folate: The Potential of 5-Methyltetrahydrofolate (5-MTHF) in Preeclampsia Prevention

Learn More

Let's talk

We're Here to Help

Contact Us

Magnafolate®

About US

Knowledge of L-methylfolate

Subscribe

Latest News

Online Service